Back

Filament Health ships PEX010 to Australia for Melbourne psilocybin trial

Verifying
  • Filament Health completed shipment of PEX010 to Australia for a University of Melbourne trial.
  • PEX010 will be used in a trial of psilocybin-assisted physiotherapy.
  • The study focuses on functional neurological disorder and is conducted by the University of Melbourne.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.